HCA Healthcare Financial Statements (HCA)
|
|
|
|
Report date
|
|
|
18.02.2022 |
17.02.2023 |
16.02.2024 |
14.02.2025 |
10.02.2026 |
|
29.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
58 752 |
60 233 |
64 968 |
70 603 |
75 600 |
|
76 388 |
|
Operating Income, bln rub |
|
|
9 678 |
9 053 |
9 627 |
10 547 |
11 965 |
|
11 973 |
|
EBITDA, bln rub |
? |
|
14 252 |
13 290 |
12 721 |
13 896 |
15 603 |
|
15 662 |
|
Net profit, bln rub |
? |
|
6 956 |
5 643 |
5 242 |
5 760 |
6 784 |
|
6 794 |
|
|
OCF, bln rub |
? |
|
8 959 |
8 522 |
9 431 |
10 514 |
12 636 |
|
12 999 |
|
CAPEX, bln rub |
? |
|
3 577 |
4 395 |
4 744 |
4 875 |
4 944 |
|
5 072 |
|
FCF, bln rub |
? |
|
5 382 |
4 127 |
4 687 |
5 639 |
7 692 |
|
7 927 |
|
Dividend payout, bln rub
|
|
|
624.0 |
653.0 |
661.0 |
690.0 |
679.0 |
|
682.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
8.97% |
11.6% |
12.6% |
12.0% |
10.0% |
|
10.0% |
|
|
OPEX, bln rub |
|
|
12 814 |
14 124 |
15 952 |
18 131 |
19 409 |
|
14 704 |
|
Cost of production, bln rub |
|
|
36 260 |
37 056 |
39 389 |
41 925 |
44 226 |
|
49 711 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
1 529 |
1 739 |
1 938 |
2 061 |
2 248 |
|
2 285 |
|
|
Assets, bln rub |
|
|
50 742 |
52 438 |
56 211 |
59 513 |
60 720 |
|
61 450 |
|
Net Assets, bln rub |
? |
|
-933.0 |
-2 767 |
-1 774 |
-2 499 |
-6 027 |
|
-6 303 |
|
Debt, bln rub |
|
|
36 726 |
40 200 |
41 859 |
45 237 |
50 198 |
|
49 845 |
|
Cash, bln rub |
|
|
1 451 |
908.0 |
935.0 |
2 021 |
1 040 |
|
940.0 |
|
Net debt, bln rub |
|
|
35 275 |
39 292 |
40 924 |
43 216 |
49 158 |
|
48 905 |
|
|
Ordinary share price, rub |
|
|
256.9 |
240.0 |
270.7 |
300.2 |
466.9 |
|
427.5 |
|
Number of ordinary shares, mln |
|
|
323.3 |
290.3 |
272.4 |
258.6 |
230.7 |
|
226.7 |
|
|
Market cap, bln rub |
|
|
83 066 |
69 672 |
73 734 |
77 620 |
107 709 |
|
96 903 |
|
EV, bln rub |
? |
|
118 341 |
108 964 |
114 658 |
120 836 |
156 867 |
|
145 808 |
|
Book value, bln rub |
|
|
-10 473 |
-12 420 |
-11 719 |
-12 592 |
-16 320 |
|
-16 807 |
|
|
EPS, rub |
? |
|
21.5 |
19.4 |
19.2 |
22.3 |
29.4 |
|
30.0 |
|
FCF/share, rub |
|
|
16.6 |
14.2 |
17.2 |
21.8 |
33.3 |
|
35.0 |
|
BV/share, rub |
|
|
-32.4 |
-42.8 |
-43.0 |
-48.7 |
-70.7 |
|
-74.2 |
|
|
EBITDA margin, % |
? |
|
24.3% |
22.1% |
19.6% |
19.7% |
20.6% |
|
20.5% |
|
Net margin, % |
? |
|
11.8% |
9.37% |
8.07% |
8.16% |
8.97% |
|
8.89% |
|
FCF yield, % |
? |
|
6.48% |
5.92% |
6.36% |
7.26% |
7.14% |
|
8.18% |
|
ROE, % |
? |
|
-745.6% |
-203.9% |
-295.5% |
-230.5% |
-112.6% |
|
-107.8% |
|
ROA, % |
? |
|
13.7% |
10.8% |
9.33% |
9.68% |
11.2% |
|
11.1% |
|
|
P/E |
? |
|
11.9 |
12.3 |
14.1 |
13.5 |
15.9 |
|
14.3 |
|
P/FCF |
|
|
15.4 |
16.9 |
15.7 |
13.8 |
14.0 |
|
12.2 |
|
P/S |
? |
|
1.41 |
1.16 |
1.13 |
1.10 |
1.42 |
|
1.27 |
|
P/BV |
? |
|
-7.93 |
-5.61 |
-6.29 |
-6.16 |
-6.60 |
|
-5.77 |
|
EV/EBITDA |
? |
|
8.30 |
8.20 |
9.01 |
8.70 |
10.1 |
|
9.31 |
|
Debt/EBITDA |
|
|
2.48 |
2.96 |
3.22 |
3.11 |
3.15 |
|
3.12 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
6.09% |
7.30% |
7.30% |
6.90% |
6.54% |
|
6.64% |
|
| HCA Healthcare shareholders |
